|Articles|May 1, 2000

May 2000
Volume 6
Issue 5

Proton Pump Inhibitor Therapy: Preliminary Results of a Therapeutic Interchange Program

Author(s)Phillip B. Amidon, MD, Rhonda Jankovich, RN, BSN, Cheryl A. Stoukides, PharmD

Download PDF: Proton Pump Inhibitor Therapy: Preliminary Results of a Therapeutic Interchange Program

Articles in this issue

almost 26 years ago

Article

Training Tomorrow's Clinicians Today - Managed Care Essentials: A Process for Curriculum Development

almost 26 years ago

Article

Relationship of Hemoglobin A1C, Age of Diabetes Diagnosis, and Ethnicity to Clinical Outcomes and Medical Costs in a Computer-Simulated Cohort of Persons with Type 2 Diabetes

almost 26 years ago

Article

Disease Management Program Improves Asthma Outcomes

almost 26 years ago

Article

Prescribing Medications for Geriatric Patients in the Managed Care Setting

almost 26 years ago

Article

The Inpatient Specialist: What is the Difference?

almost 26 years ago

Article

Teaching Managed Care Principles: We Need to Do Better

almost 26 years ago

Article

The Impact of an Inpatient Physician Program on Quality, Utilization, and Satisfaction

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Subscribe Now!

Latest CME

AJMC Supplement

Revolutionizing Acute Pain Relief: Emerging Nonopioid Therapies and the Essential Role of Managed Care

2.0 Credits / Pain Management

On-Demand Virtual Symposium

Advancing Immunotherapy in Endometrial Cancer: A Managed Care Perspective on Personalized Care

1.5 Credits / Gynecologic Cancer, Health Equity, Diversity & Inclusion, Oncology, Women's Health

On-Demand Virtual Symposium

Leveraging Managed Care to Optimize Patient Outcomes: Integrating Novel Treatments in Schizophrenia

1.5 Credits / Neurology, Psychiatry

Proton Pump Inhibitor Therapy: Preliminary Results of a Therapeutic Interchange Program

Articles in this issue

Newsletter

Related Content

Quality of Life: The Pending Outcome in Idiopathic Pulmonary Fibrosis

Increased Payments to Medicare Advantage Plans for Dually Eligible Beneficiaries

The Health Information Technology Special Issue: Tracking Expansion Across Settings, Technologies, and Stakeholders

Building Trust: Public Priorities for Health Care AI Labeling

Ambient AI Tool Adoption in US Hospitals and Associated Factors

Latest CME

Revolutionizing Acute Pain Relief: Emerging Nonopioid Therapies and the Essential Role of Managed Care

Advancing Immunotherapy in Endometrial Cancer: A Managed Care Perspective on Personalized Care

Leveraging Managed Care to Optimize Patient Outcomes: Integrating Novel Treatments in Schizophrenia

Trending on AJMC

FDA to Restrict Ingredients Used in Mass-Marketed Compounded GLP-1s, Crack Down on Misleading Ads

Contributor: Reimagining Beneficiary Engagement in Accountable Care Models to Make America Healthy Again

MID Models Reduce Adverse Events, Lower Costs in Oncology: Kenneth Komorny, PharmD, BCPS

5 Things to Know About the Oral GLP-1 Era

Medically Integrated Dispensing Helps Prevent Oncology Care Fragmentation: Katherine Tobon, PharmD, BCOP